Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Digestive System Neoplasms 3Digestive System Diseases 3Neoplasms, Glandular and Epithelial 2Neoplasms 2Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Endocrine System Diseases 2Endocrine Gland Neoplasms 2Carcinoma 2Uterine Cervical Dysplasia 1Urogenital Neoplasms 1Stomach Neoplasms 1Stomach Diseases 1Sarcoma 1Rectal Diseases 1Pancreatic Neoplasms 1Pancreatic Diseases 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Intestinal Neoplasms 1Intestinal Diseases 1Hodgkin Disease 1Head and Neck Neoplasms 1Gonadal Disorders 1Genital Neoplasms, Female 1Genital Diseases, Female 1Female Urogenital Diseases and Pregnancy Complications 1Female Urogenital Diseases 1

Interventions

GX-188 vaccine 4human papillomavirus vaccine, L1 type 16, 18 3Human Papillomavirus DNA Tests 3Colposcopy 3Blood Specimen Collection 3Vaccines 2VGX-3100 2Topotecan 2Restraint, Physical 2Paclitaxel 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Cisplatin 2Biopsy 25-aminolevulinic acid hexyl ester 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2terameprocol 1poly(gamma-glutamic acid) 1poly ICLC 1methyl 5-aminolevulinate 1epigallocatechin gallate 1artesunic acid 1artemisinin 1ZYC101a 1Watchful Waiting 1Vaccines, Synthetic 1Transurethral Resection of Prostate 1Pregnancy Tests 1Pemetrexed 1Papillomavirus Vaccines 1Ointments 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Uterine Cervical Dysplasia × Ocoxin × Clear all
NCT03549273 2024-02-07

Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

Catalysis SL

Phase 2 Unknown
62 enrolled
Gynecologic

Carcinoma, Uterine Cervical Dysplasia, Neoplasms, Neoplasms, Glandular and Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡